Vaccination requirements in patients with gastroenterological diseases (hepatitis A and B, pneumococcal and meningococcal vaccination);Impfindikationen bei gastroenterologischen krankheitsbildern (hepatitis A und B, pneumokokken, meningokokken)

Deutsche Medizinische Wochenschrift

Volumn 129, Issue SUPPL. 2, 2004, Pages

  Weinke, Thomas ^a   Guthoff W ^b   Jahn, H U ^b  

^a KLINIKUM ERNST VON BERGMANN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE;

ALCOHOLISM; FATTY LIVER; GASTROINTESTINAL DISEASE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MENINGOCOCCOSIS; MORTALITY; REVIEW; SEROCONVERSION; STREPTOCOCCUS INFECTION; VACCINATION;

GASTROINTESTINAL DISEASES; HEPATITIS A VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; MENINGOCOCCAL VACCINES; OPPORTUNISTIC INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS;

EID: 4644246138     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-831388     Document Type: Review

References (16)

1. Arguedas MR, McGuire BM, Fallen MB. Implementation of vaccination in patients with cirrhosis. Dig Dis Sci 2002; 47: 384-387
2. Arguedas MR, Johnson A, Eloubeidi MA, Fallon MB. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients. Hepatology 2001; 4: 28-31
3. Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol 2002; 51: 717-722
4. Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004; 350: 476-481
5. Dominguez M, Barcena R, Garcia M, Lopez-Sanroman A, Nuno J. Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list Liver Transplant 2000; 6: 440-442
6. Dumot JA, Barnes DS, Younossi Z, Gordon SM, Avery RK, Domen RE, Henderson JM, Carey WD. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 1999; 94: 1601-1604
7. Fabia R, Levy MF, Crippin J, Tillery W, Netto GJ, Aguanno J, Dysert P, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact Liver Transpl Surg 1998; 4: 119-127
8. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995; 90: 201-205
9. Keeffe EB, Iwarson S, McMahon BJ, Lindsay KL, Koff RS, Manns M, Baumgarten R, Wiese M, Fourneau M, Safary A, Clemens R, Krause DS. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998; 27: 881-886
10. McCashland TM, Preheim LC, Gentry-Nielsen MJ. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Inf Dis 2000; 181: 757-760
11. Offit PA, Peter G. The meningococcal vaccine - public policy and individual choices. N Engl J Med 2003; 349: 2353-2356
12. Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STI-KO) am Robert Koch-Institut. Epidem Bull 2003; 30: 235-250
13. Senturk H, Tabak F, Akdogan M, Erdem L, Mert A, Ozaras R, Sander E, Ozbay G, Badur S. Therapeutic vaccination in chronic hepatitis B. J Gastroenterol Hepatol 2002; 17: 72-76
14. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, Ferraro T, Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998; 338: 286-290
15. Villeneuve E, Vincelette J, Villeneuve JP. Ineffectiveness of hepatitis B vaccination in cirrhotic patients waiting for liver transplantation. Can J Gastroenterol 2000; 14: 59B-62B(Suppl B
16. Whitney CG, Schaffner W, Butler JC. Rethinking recommendations for use of pneumococcal vaccines in adults. Clin Inf Dis 2001; 33: 662-675